Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia (Q46251338)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q97105325)
(Q90584721)
(P304) 752-759
(P433) 4
(P478) 43
(P577) Saturday, April 1, 2006
(P921) (Q181600)
(P1433) (Q15755733)
(P1476) "Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia" (language: en)
(P2093) Eric P Brass
Richard Anthony
John Dormandy
Jenny Jiao
Atsushi Nakanishi
Mark Nehler
Circulase investigators
other details
description scientific article

External Links